We are a national coalition of AIDS activists, many living with HIV/AIDS,working together to end the AIDS epidemic by advancing research on HIV/AIDS

ATAC Pharmaceutical Progress Report 2010

In 2009, ATAC released its first report card evaluation of each company's strength and weaknesses grading them in several categories important to the HIV community.

In October of 2010, ATAC issued progress reports to each company updating them on their activities during the past year and since the release of the 2009 report card, in an effort to keep both the companies and the community informed about ATAC's expectations for future improvements.

Click on the below links for individual company progress reports.

Abbott Laboratories

Bristol-Myers Squibb

Boehringer Ingelheim

Genentech

Gilead

Merck

Tibotec

ViiV